Physician profile
Deepak P Edward
NPI 1144230293
$52,860.36
in general payments reported to CMS, 2019-2025
9 companies · $43.85 in 2025
The $43.85 reported for 2025 was less than what a typical Glaucoma Specialist provider received nationally (typical 2025 total: $608).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11K · 2021: $29K · 2022: $34.28 · 2023: $14K · 2024: $61.87 · 2025: $43.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Food and Beverage: $361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,398.00 |
| Food and Beverage | $360.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $20,588.20 | 2021 | |
| Astrazeneca Uk Limited | $12,648.00 | 2020-2023 | |
| Genentech, INC. | $7,850.00 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $7,200.00 | 2023 | |
| Abbvie INC. | $4,281.81 | 2023-2025 | Xen Glaucoma Treatment System |
| Aerie Pharmaceuticals, INC. | $129.22 | 2021 | |
| Carl Zeiss Meditec USA, INC. | $115.33 | 2023 | Iolmaster 700 |
| Alcon Vision LLC | $24.84 | 2022 | |
| New World Medical,INC. | $22.96 | 2022-2024 | Kahook Dual Blade, Ahmed Glaucoma Valve, Streamline |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepak Edward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.